Vitamin D ist das am meisten diskutierte Nahrungsergänzungsmittel in Deutschland – und gleichzeitig das am häufigsten fehlende. Über die Hälfte der deutschen Erwachsenen hat eine Unterversorgung, rund 15 % einen ausgeprägten Mangel. Zwischen Oktober und März kann die Haut in Deutschland praktisch kein Vitamin D bilden.
.gif)
High-dose vitamin D supplements (>4,000 IU/day) should only be taken under medical supervision. Last updated: February 2026.
Vitamin D is the most widely taken dietary supplement in the UK — and at the same time one of the most misunderstood. It is not a classic vitamin but a prohormone that the body produces itself. 80–90% of supply comes from the skin's own production under UV-B radiation — not from diet. This explains why between October and March in the UK virtually no endogenous synthesis is possible, and why a large portion of the population is seasonally deficient.
| Property | Details |
|---|---|
| Active substance | Cholecalciferol (vitamin D3) / ergocalciferol (vitamin D2) |
| ATC code | A11CC05 |
| Drug class | Fat-soluble vitamin / prohormone |
| Available forms | Drops, capsules, tablets, injection solution |
| Blood test value | 25-hydroxyvitamin D (25-OH-D) in nmol/L or ng/mL |
| UK RNI / SACN recommendation | 400 IU/day (10 µg) for the general population; 400 IU year-round for at-risk groups |
| EFSA upper limit (UL) | 4,000 IU/day (100 µg) for adults |
| Prescription status | No (as supplement); higher therapeutic doses may require prescription |
| Special feature | 80–90% of supply from sunlight — not achievable October–March in the UK |
The term "vitamin" is biologically imprecise: a true vitamin must be obtained from the diet because the body cannot make it. Vitamin D, by contrast, is produced by the body in the skin under UV-B radiation — and is then converted in the liver and kidneys into the active hormone calcitriol. This hormone binds to receptors in virtually every tissue in the body and regulates gene expression there. More than 200 genes are under the direct or indirect influence of vitamin D.
This explains why vitamin D deficiency has such wide-ranging consequences — and why its effects extend beyond classic bone metabolism. A 2024 analysis of the VITAL trial showed: daily vitamin D supplementation reduces cancer mortality by 12%. This is not proof of cancer prevention by vitamin D alone — but a signal that deserves attention.
| Function | Effect of deficiency |
|---|---|
| Calcium & bone metabolism | Rickets (children), osteomalacia, osteoporosis |
| Immune system | Increased susceptibility to infection, autoimmune conditions |
| Muscle function | Muscle weakness, increased fall risk in older adults |
| Cardiovascular system | Associations with increased risk of arrhythmias, hypertension |
| Cancer prevention | VITAL trial analysis 2024: daily supplementation reduces cancer mortality by 12% |
| Mood | Associated with depression, seasonal affective disorder |
Vitamin D deficiency is widespread in the UK — NHS data and national surveys indicate that around 1 in 5 people have low blood levels, rising substantially in winter. Certain groups carry a particularly high risk.
| Risk group | Why? |
|---|---|
| Older adults >65 years | Reduced skin synthesis, less sun exposure, impaired renal activation |
| Patients on prednisolone/corticosteroids | Steroids increase bone loss → vitamin D + calcium from day 1! |
| Dark skin | Melanin blocks UV-B → up to 6× less synthesis |
| Covered skin / limited sun exposure | No skin synthesis possible |
| Housebound / care home residents | No regular sun contact |
| Obesity (BMI >30) | Vitamin D sequestered in adipose tissue; less bioavailable |
| Pregnant & breastfeeding women | Increased demand for mother and baby |
| Malabsorption (Crohn's, coeliac disease) | Reduced intestinal absorption (fat-soluble vitamin!) |
| Chronic kidney disease | Reduced activation of vitamin D (25-OH-D → calcitriol in the kidney) |
| Infants | Minimal sun contact; low levels in breast milk |
The laboratory value for vitamin D is 25-hydroxyvitamin D (25-OH-D) — and appears in UK lab results in two units: nmol/L or ng/mL. The conversion factor is 2.5: 50 nmol/L = 20 ng/mL. This regularly causes confusion. Both units are shown in the table below.
SACN (UK) defines sufficiency from 25 nmol/L, and NHS guidance considers levels below 25 nmol/L to indicate deficiency. Many experts favour an optimal range of 50–125 nmol/L (20–50 ng/mL) — a range at which bones, muscles, and the immune system are well supplied without the risk of toxic levels. International guidelines (JCEM 2024) recommend focusing testing and supplementation on at-risk groups — routine screening in healthy adults is not recommended.
| 25-OH-D (nmol/L) | 25-OH-D (ng/mL) | Assessment |
|---|---|---|
| <25 | <10 | Deficiency → treatment required! |
| 25–50 | 10–20 | Insufficiency → supplementation recommended |
| 50–125 | 20–50 | Sufficient — optimal: 50–125 nmol/L (20–50 ng/mL) |
| 125–250 | 50–100 | Elevated, but usually not yet toxic |
| >250 | >100 | Potentially toxic → hypercalcaemia risk! |
The correct dose depends on baseline status, risk profile, and whether a deficiency is present. For most adults in the UK: 400–1,000 IU daily is safe and effective, particularly between October and March when sunlight is insufficient for endogenous synthesis.
| Group | Recommended dose | Note |
|---|---|---|
| Healthy adults (prevention) | 400 IU/day (SACN/NHS) | Year-round for at-risk groups; October–March for all |
| Adults with risk factors | 1,000–2,000 IU/day | With confirmed deficiency or risk factor |
| Severe deficiency (<25 nmol/L) | Loading dose: 50,000–100,000 IU per week | Under medical supervision only! Then maintenance dose |
| On corticosteroids (prednisolone) | 800–1,000 IU/day + calcium 1,000 mg | From day 1 of corticosteroid therapy! |
| Infants (under 1 year) | 400 IU/day | NHS recommendation for all breastfed infants |
| Children (1–4 years) | 400 IU/day | NHS recommendation year-round |
| Older adults >65 years | 800–1,000 IU/day | Bone and falls prevention |
| EFSA upper limit (UL) | 4,000 IU/day | Do not exceed without medical supervision! |
High-dose weekly preparations (e.g. 20,000 IU per tablet) are available but are not optimal according to current evidence. Data from the VITAL trial and related analyses show that daily low doses (400–2,000 IU) are more effective for long-term vitamin D status than infrequent high-dose administration. The body can only metabolise a limited amount of vitamin D at once. Additionally: vitamin D is fat-soluble — it must be taken with a fat-containing meal, otherwise a significant portion is not absorbed. Taking vitamin D on an empty stomach wastes efficacy.
This is one of the most important facts about vitamin D: the skin has a built-in protection mechanism. Once enough vitamin D3 has been formed in the skin, excess provitamin is broken down — overdose from sunlight is biologically impossible. Vitamin D toxicity can only arise from supplements or medications.
It becomes dangerous from sustained intake above 4,000 IU daily — or from a single massive overdose (e.g. confusing IU with µg, or a decimal error when measuring drops). The result is hypercalcaemia: too much calcium in the blood from excessive calcium absorption from the gut.
| Dose | Risk assessment |
|---|---|
| Up to 1,000 IU/day | Safe — no monitoring needed |
| 1,000–2,000 IU/day | Safe for most adults |
| 2,000–4,000 IU/day | EFSA upper limit. Consider monitoring with long-term use |
| >4,000 IU/day | Medical supervision only! Hypercalcaemia risk increases |
| >10,000 IU/day long-term | Toxic! Severe hypercalcaemia risk |
This is the most clinically important vitamin D indication after bone health: anyone taking prednisolone or other glucocorticoids must supplement vitamin D and calcium from the outset. This is not optional advice — it is a guideline-based requirement.
In practice, this is alarmingly often overlooked: brite data show that a significant proportion of patients on prednisolone are not supplementing vitamin D. Anyone receiving a prescription for prednisolone should ask about vitamin D and calcium at the same appointment — or use the interaction check.
Vitamin D has several clinically relevant interactions, primarily through its effect on calcium levels. Particularly important: the interaction with digoxin and with thiazide diuretics. Check all combinations with the interaction check.
| Medication | Interaction | Recommendation |
|---|---|---|
| Prednisolone / corticosteroids | Bone loss ↑ → vitamin D + calcium essential | Supplement from day 1! |
| Digoxin | Vitamin D raises calcium → enhanced glycoside toxicity! | Monitor calcium levels! |
| Thiazide diuretics (HCTZ) | Less calcium excretion → hypercalcaemia risk with high vitamin D doses | Monitor calcium |
| Torasemide / furosemide | More calcium excretion → vitamin D counteracts this | Vitamin D beneficial with loop diuretics |
| Pantoprazole (long-term) | Magnesium deficiency → impairs vitamin D activation | Monitor magnesium |
| Anticonvulsants (phenytoin, carbamazepine) | Accelerated vitamin D breakdown (CYP induction) | Higher doses may be needed; monitor levels |
| Orlistat (weight-loss medication) | Fat-soluble vitamins absorbed less well | Take vitamin D separately from orlistat; stagger timing |
A persistent claim circulates online: "Vitamin D without K2 is dangerous — calcium deposits in the blood vessels!" This sounds plausible, but according to the current state of research at normal dosing levels, it is not scientifically supported. The German Federal Institute for Risk Assessment (BfR) explicitly concluded in its 2024 position statement that there is no demonstrated benefit for combining vitamin D with vitamin K2 at normal doses up to 2,000 IU daily. Vitamin K2 is simply not necessary alongside low-dose vitamin D.
At very high vitamin D doses above 4,000 IU daily (under medical supervision) K2 can be discussed — but that is the exception, not the rule. For the majority of people taking 400–2,000 IU daily: K2 is optional, not essential.
| Supplement | Evidence | Recommendation |
|---|---|---|
| Calcium | Well established for osteoporosis prevention | Yes — 1,000 mg/day (preferably via diet: dairy, leafy greens, fortified foods) |
| Vitamin K2 | Mechanistic theory — clinical evidence weak | Not essential at ≤2,000 IU/day. BfR (2024): benefit not demonstrated. |
| Magnesium | Required cofactor for vitamin D activation | Worthwhile when magnesium-deficient — e.g. on pantoprazole or diuretics |
| Vitamin A (high-dose) | Can antagonise vitamin D action | Do not combine high-dose vitamin A with vitamin D without medical advice |
| Observation | Frequency | Typical comment |
|---|---|---|
| No vitamin D while on corticosteroids | Very common | "Why did nobody recommend vitamin D? I've been on prednisolone for months." |
| High-dose supplements without medical supervision | Common | "I was taking 10,000 IU a day — the app warned me." |
| Deficiency never tested | Common | "My level was 8 ng/mL — nobody had ever tested it." |
| Taking without food | Occasional | "I was taking vitamin D on an empty stomach — the app said: take with food!" |
| K2 confusion from online myths | Common | "Do I really need K2 with it? Online it says it's dangerous without K2." |
Vitamin D daily dose — how much is right? For healthy adults in the UK: 400 IU daily (SACN/NHS recommendation), particularly October to March. With risk factors (older age, dark skin, little sun exposure, obesity): 1,000–2,000 IU. With confirmed severe deficiency: higher loading doses under medical supervision, then a maintenance dose. A practical guide: 400–1,000 IU daily is safe and appropriate for most people in the UK.
Vitamin D blood level table — what does my result mean? The reference range varies between labs, but the scientific consensus is clear: below 25 nmol/L (below 10 ng/mL) is deficiency; below 50 nmol/L (below 20 ng/mL) is insufficiency. Many experts regard 50–125 nmol/L (20–50 ng/mL) as the optimal range. Important: the two units (nmol/L and ng/mL) differ by a factor of 2.5 — this regularly causes confusion when reading lab reports.
Vitamin D overdose symptoms — how do I recognise them? Hypercalcaemia (too much calcium in the blood from excessive vitamin D action) presents as persistent nausea, vomiting, excessive thirst, frequent urination, confusion, muscle weakness, and in severe cases cardiac arrhythmias. Important: overdose from sunlight is not possible — only from supplements. At 400–2,000 IU daily, toxicity is virtually excluded.
Vitamin D and K2 together — do I need both? No — according to the BfR (German Federal Institute for Risk Assessment, position statement 2024), the benefit of adding K2 at normal vitamin D dosing (up to 2,000 IU) is not demonstrated. The widely circulated online claim that vitamin D without K2 dangerously deposits calcium in the blood vessels is not scientifically confirmed at normal dosing levels. K2 in moderate amounts probably does no harm — but at low to moderate vitamin D doses it is simply not necessary.
Vitamin D and corticosteroids — why is the combination so important? Glucocorticoids (prednisolone) interfere with calcium balance in two ways: they inhibit calcium absorption in the gut and activate bone resorption. The result without countermeasures: glucocorticoid-induced osteoporosis with elevated fracture risk, particularly in the spine. Vitamin D (800–1,000 IU) + calcium (1,000 mg) must be taken from the first day of any corticosteroid therapy lasting more than 3 months. NICE (NG187, 2023) and the BSR are unequivocal on this point.